Medication count, including statin or metformin use, is not associated with influenza vaccine responses in older adults
Abstract
Background: Vaccination helps prevent infections and associated sequelae, especially in older adults. Since the degree to which vaccine responses are influenced by medications is not well described, we examined the association of medication count, including statin or metformin use, with influenza vaccine responsiveness.
Methods: A secondary analysis of data from 542 participants aged 65 years and older randomized to receive either the standard or high dose vaccine during four influenza seasons (2015-2018) was conducted. Medication counts, as well as statin and metformin usage, were self-reported. Associations between vaccine antibody titer responses and medication usage were estimated using mixed model linear regression.
Results: Participants reported taking a median of five medications, with 45 % (n = 244) of participants using a statin and 12 % (n = 65) metformin. Medication use was higher with frailty, chronic condition count and in males. Our data showed that medication use was not broadly associated with vaccine responsiveness, which held after adjusting for frailty and number of chronic conditions, and when investigated within sex and vaccine dose strata. However, within diabetics, the strong boosting effect of the high-dose vaccine was significantly dampened for metformin users (n = 64) as compared to non-users (n = 30), but still remained slightly higher than standard-dose responses. This dampening effect was evident in analyses where all antigen-specific responses…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 542 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.